164 related articles for article (PubMed ID: 32437637)
41. Computed tomographic measurement of airway remodeling and emphysema in advanced chronic obstructive pulmonary disease. Correlation with pulmonary hypertension.
Dournes G; Laurent F; Coste F; Dromer C; Blanchard E; Picard F; Baldacci F; Montaudon M; Girodet PO; Marthan R; Berger P
Am J Respir Crit Care Med; 2015 Jan; 191(1):63-70. PubMed ID: 25393421
[TBL] [Abstract][Full Text] [Related]
42. Pulmonary arterial hypertension in France: results from a national registry.
Humbert M; Sitbon O; Chaouat A; Bertocchi M; Habib G; Gressin V; Yaici A; Weitzenblum E; Cordier JF; Chabot F; Dromer C; Pison C; Reynaud-Gaubert M; Haloun A; Laurent M; Hachulla E; Simonneau G
Am J Respir Crit Care Med; 2006 May; 173(9):1023-30. PubMed ID: 16456139
[TBL] [Abstract][Full Text] [Related]
43. Pulmonary arterial hypertension and lung transplantation.
Lordan JL; Corris PA
Expert Rev Respir Med; 2011 Jun; 5(3):441-54. PubMed ID: 21702664
[TBL] [Abstract][Full Text] [Related]
44. [Risk factors for death and the clinical features of different subtypes of patients with pulmonary arterial hypertension related to congenital heart disease].
Xu ZY; Li QQ; Zhang C; Zhang HS; Gu H
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):315-322. PubMed ID: 32370483
[No Abstract] [Full Text] [Related]
45. [Clinical and hemodynamic characteristics and possibilities for therapy in patients with severe (functional class IV) pulmonary arterial hypertension associated with diffuse connective tissue diseases].
Nikolaeva EV; Yudkina NN; Kurmukov IA; Novikova DS; Markelova EI; Volkov AV
Ter Arkh; 2015; 87(5):24-32. PubMed ID: 26155616
[TBL] [Abstract][Full Text] [Related]
46. An emerging phenotype of pulmonary arterial hypertension patients carrying
Montani D; Lechartier B; Girerd B; Eyries M; Ghigna MR; Savale L; Jaïs X; Seferian A; Jevnikar M; Boucly A; Riou M; Traclet J; Chaouat A; Levy M; Le Pavec J; Fadel E; Perros F; Soubrier F; Remy-Jardin M; Sitbon O; Bonnet D; Humbert M
Eur Respir J; 2022 Dec; 60(6):. PubMed ID: 35618278
[TBL] [Abstract][Full Text] [Related]
47. Clinical characterisation of 29 neurofibromatosis type-1 patients with molecularly ascertained 1.4 Mb type-1 NF1 deletions.
Mautner VF; Kluwe L; Friedrich RE; Roehl AC; Bammert S; Högel J; Spöri H; Cooper DN; Kehrer-Sawatzki H
J Med Genet; 2010 Sep; 47(9):623-30. PubMed ID: 20543202
[TBL] [Abstract][Full Text] [Related]
48. Mid-aortic syndrome with renovascular hypertension and multisystem involvement in a girl with familiar neurofibromatosis von Recklinghausen type 1.
Petrak B; Bendova S; Seeman T; Klein T; Lisy J; Zatrapa T; Marikova T
Neuro Endocrinol Lett; 2007 Dec; 28(6):734-8. PubMed ID: 18063929
[TBL] [Abstract][Full Text] [Related]
49. Pulmonary arterial hypertension in systemic lupus erythematosus based on a CSTAR-PAH study: Baseline characteristics and risk factors.
Zhang N; Li M; Qian J; Wang Q; Zhao J; Yang Z; Tian Z; Zhang X; Zuo X; Zhang M; Zhu P; Ye S; Zhang W; Zheng Y; Qi W; Li Y; Zhang Z; Ding F; Gu J; Liu Y; Wei W; Zeng X
Int J Rheum Dis; 2019 May; 22(5):921-928. PubMed ID: 30746850
[TBL] [Abstract][Full Text] [Related]
50. Survival in pulmonary hypertension due to chronic lung disease: Influence of low diffusion capacity of the lungs for carbon monoxide.
Rose L; Prins KW; Archer SL; Pritzker M; Weir EK; Misialek JR; Thenappan T
J Heart Lung Transplant; 2019 Feb; 38(2):145-155. PubMed ID: 30391191
[TBL] [Abstract][Full Text] [Related]
51. Four- and seven-year outcomes of patients with congenital heart disease-associated pulmonary arterial hypertension (from the REVEAL Registry).
Barst RJ; Ivy DD; Foreman AJ; McGoon MD; Rosenzweig EB
Am J Cardiol; 2014 Jan; 113(1):147-55. PubMed ID: 24176071
[TBL] [Abstract][Full Text] [Related]
52. Long-term outcomes of pulmonary arterial hypertension under specific drug therapy in Eisenmenger syndrome.
Hascoët S; Baruteau AE; Humbert M; Simonneau G; Jais X; Petit J; Laux D; Sitbon O; Lambert V; Capderou A
J Heart Lung Transplant; 2017 Apr; 36(4):386-398. PubMed ID: 27866929
[TBL] [Abstract][Full Text] [Related]
53. Hemodynamic and functional assessment of patients with sickle cell disease and pulmonary hypertension.
Anthi A; Machado RF; Jison ML; Taveira-Dasilva AM; Rubin LJ; Hunter L; Hunter CJ; Coles W; Nichols J; Avila NA; Sachdev V; Chen CC; Gladwin MT
Am J Respir Crit Care Med; 2007 Jun; 175(12):1272-9. PubMed ID: 17379852
[TBL] [Abstract][Full Text] [Related]
54. Echocardiography, 6-minute walk distance, and distance-saturation product as predictors of pulmonary arterial hypertension in idiopathic pulmonary fibrosis.
Modrykamien AM; Gudavalli R; McCarthy K; Parambil J
Respir Care; 2010 May; 55(5):584-8. PubMed ID: 20420729
[TBL] [Abstract][Full Text] [Related]
55. Survival and prognostic factors in systemic sclerosis-associated pulmonary hypertension: a systematic review and meta-analysis.
Lefèvre G; Dauchet L; Hachulla E; Montani D; Sobanski V; Lambert M; Hatron PY; Humbert M; Launay D
Arthritis Rheum; 2013 Sep; 65(9):2412-23. PubMed ID: 23740572
[TBL] [Abstract][Full Text] [Related]
56. Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry.
Badesch DB; Raskob GE; Elliott CG; Krichman AM; Farber HW; Frost AE; Barst RJ; Benza RL; Liou TG; Turner M; Giles S; Feldkircher K; Miller DP; McGoon MD
Chest; 2010 Feb; 137(2):376-87. PubMed ID: 19837821
[TBL] [Abstract][Full Text] [Related]
57. Inhaled Treprostinil in Pulmonary Hypertension Associated with Lung Disease.
Faria-Urbina M; Oliveira RKF; Agarwal M; Waxman AB
Lung; 2018 Apr; 196(2):139-146. PubMed ID: 29275453
[TBL] [Abstract][Full Text] [Related]
58. A molecular analysis of individuals with neurofibromatosis type 1 (NF1) and optic pathway gliomas (OPGs), and an assessment of genotype-phenotype correlations.
Sharif S; Upadhyaya M; Ferner R; Majounie E; Shenton A; Baser M; Thakker N; Evans DG
J Med Genet; 2011 Apr; 48(4):256-60. PubMed ID: 21278392
[TBL] [Abstract][Full Text] [Related]
59. Pulmonary arterial hypertension in idiopathic inflammatory myopathies: Data from the French pulmonary hypertension registry and review of the literature.
Sanges S; Yelnik CM; Sitbon O; Benveniste O; Mariampillai K; Phillips-Houlbracq M; Pison C; Deligny C; Inamo J; Cottin V; Mouthon L; Launay D; Lambert M; Hatron PY; Rottat L; Humbert M; Hachulla E
Medicine (Baltimore); 2016 Sep; 95(39):e4911. PubMed ID: 27684828
[TBL] [Abstract][Full Text] [Related]
60. Prevalence, predictors, and survival in pulmonary hypertension related to end-stage chronic obstructive pulmonary disease.
Andersen KH; Iversen M; Kjaergaard J; Mortensen J; Nielsen-Kudsk JE; Bendstrup E; Videbaek R; Carlsen J
J Heart Lung Transplant; 2012 Apr; 31(4):373-80. PubMed ID: 22226804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
